Alivus Life Sciences Ltd (543322) Stock Price & News

Why is 543322 down 2.56%?

Dive Deeper

543322:BOM

Alivus Life Sciences Ltd

₹1,308.70

-2.56%

(-34.45) 1D

Oct 16, 3:08:10 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 543322...

Open

₹1,328.55

High

₹1,336.50

Low

₹1,305.25

Mkt. cap

160.77B

Avg. vol.

9.92K

Volume

2.27K

Dividend

0.38%

Quarterly dividend

₹1.25

Ex-dividend date

Sep 1, 2026

P/E ratio

26.69

52-wk high

₹1,495.30

52-wk low

₹830.00

EPS

₹49.03

No. of employees

Open

₹1,328.55

High

₹1,336.50

Low

₹1,305.25

Mkt. cap

160.77B

Avg. vol.

9.92K

Volume

2.27K

Dividend

0.38%

Quarterly dividend

₹1.25

Ex-dividend date

Sep 1, 2026

P/E ratio

26.69

52-wk high

₹1,495.30

52-wk low

₹830.00

EPS

₹49.03

No. of employees

News stories

From web sources and news partners

Inc.com

38 minutes ago

Stock Pickers’ Long Odds Have a History

Benzinga

24 minutes ago

Stock Market Today: Dow, S&P 500 Futures Rise as Bessent Intensifies Economic Pressure on Iran, Treasury

FXStreet

2 hours ago

Dow Jones futures lead market gains following comments from US financial leaders

BigGo Finance

5 hours ago

Dow Surges 556 Points as Philadelphia Semiconductor Index Extends Losing Streak to Seven Sessions; Capital Rotates into Defensive Stocks

About Alivus Life Sciences Ltd

CEOYasir Rawjee

Employees2.27K

Founded2001

Headquarters-

SectorPharmaceutical industry

Websitealivus.com

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5.88B	6.73B	6.89B	6.40B
Cost of goods sold	2.49B	2.76B	3.45B	2.55B
Cost of revenue	2.49B	2.76B	3.45B	2.55B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	664.00M	663.70M	965.39M	682.45M
Operating expense	1.78B	1.85B	1.49B	1.94B
Total operating expenses	4.27B	4.61B	4.94B	4.49B
Operating income	1.61B	2.12B	1.95B	1.91B
Other non operating income	147.20M	139.28M	-368.69M	224.01M
EBT including unusual items	1.74B	1.98B	2.16B	2.12B
EBT excluding unusual items	1.74B	2.24B	1.78B	2.12B
Income tax expense	441.11M	481.31M	531.38M	521.47M
Effective tax rate	25.33%	24.26%	24.62%	24.57%
Other operating expenses	934.91M	988.28M	325.80M	1.05B
Net income	1.30B	1.50B	1.63B	1.60B
Net profit margin	22.11%	22.33%	23.60%	25.00%
Earnings per share	10.58	13.80	13.22	13.01
Interest and investment income	-	-	9.66M	-
Interest expense	-13.18M	-14.94M	-13.09M	-13.07M
Net interest expenses	-13.18M	-14.94M	-3.43M	-13.07M
Depreciation and amortization charges	184.35M	196.58M	202.00M	205.85M
EBITDA	1.78B	2.25B	2.11B	2.10B
Gain or loss from assets sale	-	-	-	-

Ask anything